Literature DB >> 27347094

Long form collapsin response mediator protein-1 promotes the migration and invasion of osteosarcoma cells.

Huige Hou1, Lin Chen2, Zhengang Zha1, Shaohui Cai3, Minghui Tan4, Guoqing Guo4, Ning Liu1, Guorong She1, Songwei Xun1.   

Abstract

It has been reported that long form collapsin response mediator protein-1 (LCRMP-1) promotes the metastasis of non-small cell lung cancer. Osteosarcoma (OS) is a human cancer with a high potential for metastasis. The present study aimed to investigate the role of LCRMP-1 in OS metastasis. The expression of LCRMP-1 in OS specimens and cell lines was evaluated using reverse transcription-quantitative polymerase chain reaction (RT-qPCR) and western blot analysis. Furthermore, the migration and invasion of OS cells with LCRMP-1-knockdown was investigated to examine the role of LCRMP-1 in OS metastasis. In addition, the expression of N-cadherin and matrix metalloproteinases (MMPs), which are involved in cell migration, was evaluated using RT-qPCR. Increased expression of LCRMP-1 was observed in the OS tissues and cell lines, accompanied by the enhanced migration and invasion of the OS cells. LCRMP-1-knockdown resulted in a significant decrease in the expression of N-cadherin and MMPs, as well as inhibition of the migration and invasion of the OS cells. Overexpression of LCRMP-1 promoted OS metastasis. Therefore, LCRMP-1 may be a promising target for the effective treatment of OS.

Entities:  

Keywords:  invasion; long form collapsin response mediator protein-1; migration; osteosarcoma

Year:  2016        PMID: 27347094      PMCID: PMC4906928          DOI: 10.3892/ol.2016.4562

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  18 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 2.  Osteosarcoma: anatomic and histologic variants.

Authors:  Michael J Klein; Gene P Siegal
Journal:  Am J Clin Pathol       Date:  2006-04       Impact factor: 2.493

Review 3.  Tumor metastasis: mechanistic insights and clinical challenges.

Authors:  Patricia S Steeg
Journal:  Nat Med       Date:  2006-08       Impact factor: 53.440

4.  Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate.

Authors:  Paul A Meyers; Cindy L Schwartz; Mark Krailo; Eugenie S Kleinerman; Donna Betcher; Mark L Bernstein; Ernest Conrad; William Ferguson; Mark Gebhardt; Allen M Goorin; Michael B Harris; John Healey; Andrew Huvos; Michael Link; Joseph Montebello; Helen Nadel; Michael Nieder; Judith Sato; Gene Siegal; Michael Weiner; Robert Wells; Lester Wold; Richard Womer; Holcombe Grier
Journal:  J Clin Oncol       Date:  2005-03-20       Impact factor: 44.544

5.  Collapsin response mediator protein 1 mediates reelin signaling in cortical neuronal migration.

Authors:  Naoya Yamashita; Yutaka Uchida; Toshio Ohshima; Syu-ichi Hirai; Fumio Nakamura; Masahiko Taniguchi; Katsuhiko Mikoshiba; Jérôme Honnorat; Pappachan Kolattukudy; Nicole Thomasset; Kohtaro Takei; Takuya Takahashi; Yoshio Goshima
Journal:  J Neurosci       Date:  2006-12-20       Impact factor: 6.167

6.  Collapsin response mediator protein-1 and the invasion and metastasis of cancer cells.

Authors:  J Y Shih; S C Yang; T M Hong; A Yuan; J J Chen; C J Yu; Y L Chang; Y C Lee; K Peck; C W Wu; P C Yang
Journal:  J Natl Cancer Inst       Date:  2001-09-19       Impact factor: 13.506

Review 7.  Osteosarcoma.

Authors:  P A Meyers; R Gorlick
Journal:  Pediatr Clin North Am       Date:  1997-08       Impact factor: 3.278

Review 8.  Osteosarcoma: Current Treatment and a Collaborative Pathway to Success.

Authors:  Michael S Isakoff; Stefan S Bielack; Paul Meltzer; Richard Gorlick
Journal:  J Clin Oncol       Date:  2015-08-24       Impact factor: 44.544

Review 9.  Collapsin response mediator protein-1: a novel invasion-suppressor gene.

Authors:  Jin-Yuan Shih; Yuan-Chii G Lee; Shuenn-Chen Yang; Tse-Ming Hong; Chi-Ying F Huang; Pan-Chyr Yang
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

10.  Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program.

Authors:  Lisa Mirabello; Rebecca J Troisi; Sharon A Savage
Journal:  Cancer       Date:  2009-04-01       Impact factor: 6.860

View more
  1 in total

Review 1.  Upregulated N-cadherin expression is associated with poor prognosis in epithelial-derived solid tumours: A meta-analysis.

Authors:  Yong Luo; Ting Yu; Qiongwen Zhang; Qingyu Fu; Yuzhu Hu; Mengmeng Xiang; Haoning Peng; Tianying Zheng; Li Lu; Huashan Shi
Journal:  Eur J Clin Invest       Date:  2018-02-25       Impact factor: 4.686

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.